The World Anti-Doping Agency will not appeal Swiatek's case
The World Anti-Doping Agency said on Monday that it will not appeal in the Iga Swiatek doping case.
The statement says: "The World Anti-Doping Agency (WADA) confirms that, after careful consideration, it will not file an appeal with the Court of Arbitration for Sport (CAS) in the case of Polish tennis player Iga Swiatek, who tested positive for the banned substance trimetazidine (TMZ) in August 2024.
On November 28, the International Tennis Integrity Agency (ITIA), the independent body that implements anti-doping programs on behalf of the International Tennis Federation, announced that Swiatek had accepted a one-month period of suspension after the ITIA determined that her positive test for TMZ had been caused by a contaminated melatonin product, regulated as a medicine in Poland, which had come from a reputable pharmacy in that country.
WADA has carried out a full review of the file relating to the ITIA decision, which it received on November 29.
WADA's scientific experts have confirmed that the specific scenario of contaminated melatonin, as presented by the sportswoman and accepted by the ITIA, is plausible and that there would be no scientific reason to contest it at CAS.
In addition, WADA sought the advice of external legal counsel, who considered that the athlete's explanation of contamination was well supported, that the ITIA's decision was consistent with the World Anti-Doping Code, and that there was no reasonable basis to appeal the case to CAS."
Davis Cup: between reforms, criticism and national culture 
The paradox dividing tennis: exhausted players and a saturated calendar, yet ever more exhibitions 
Training future champions: spotlight on the decline of the French public model facing private academies 
Is padel threatening tennis? Inside the revolution shaking up the established order 